• Publications
  • Influence
A Treatment of Metastatic Renal Cell Carcinoma: The Cost Effectiveness of Axitinib From a Malaysian Perspective
Background: Axitinib has been suggested to be effective as a second line treatment of metastatic renal cell carcinoma. However, its adoption may be limited by its financial consequences. Therefore, aExpand
Psychometric evaluation of the Malay version of the Impact of Weight on Quality of Life-Lite (IWQOL-LITE) questionnaire
Background : The availability of obesity specific quality of life measurement tool is limited. The Malay version of Impact of Weight on Quality of Life-Lite is an obesity specific quality of lifeExpand
A cross-sectional study of hypertensive outpatients to determine the necessity of asking about erectile dysfunction symptoms : original research
Background: Erectile dysfunction (ED) is common amongst hypertensive men. Hypertensive patients often attribute it to antihypertensive drugs, although conflicting evidence linking ED withExpand
Comparisons between backs questionnaire and other existing questionnaires against standards set by a social security organization based in a developing country
In a country that struggles on safety standards and relying heavily on manual labour, Malaysia over the decade had to be very objective in defining work- relatedness among musculoskeletal disorderExpand
Body plethysmography for measuring airway resistance in patients with bilateral vocal fold immobility.
OBJECTIVE This study investigated the reliability of body plethysmography in comparison to spirometry in objectively measuring upper airway functions. METHODS The study population consisted of 53Expand
An Economic Evaluation of Everolimus As Second Line Treatment of Metastatic Renal Cell Carcinoma: A Malaysian Perspective
Background: Everolimus as second line treatment of metastatic renal cell carcinoma are significantly effective but more expensive compared with best supportive care alone. Therefore, a cost-utilityExpand
An Economic Evaluation of Sunitinib Versus Pazopanib As First Line Treatment of Metastatic Renal Cell Carcinoma
Background: Sunitinib and pazopanib have been shown to benefit the metastatic renal cell carcinoma patients as evidence suggested that these treatments have a comparable clinical effectiveness.Expand